Aposense Ltd.   Report issue

For profit Phase 2
Founded: Petah Tiqva Israel (1996)

Organization Overview

First Clinical Trial
2008
NCT00696943
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now